top of page

Search


Stay Informed With Sanil | Sanil Pinto
Mar 25, 20239 min read
Brokerage Report: Zydus Lifesciences Ltd: Multiple growth engines to drive profitable growth
Brokerage Report: Zydus Lifesciences Ltd: Multiple growth engines to drive profitable growth

Stay Informed With Sanil | Sanil Pinto
Mar 24, 20234 min read
Brokerage Report On Ajanta Pharma, March 2023. Should You Buy, Sell or Hold?
We continue to value Aja at 22x 12M forward earnings to arrive at our TP of INR1,410.
bottom of page